Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
5.49%
operating margin TTM
7.34%
revenue TTM
70.06 Million
revenue per share TTM
0.9$
valuation ratios | |
|---|---|
| pe ratio | 64.72 |
| peg ratio | 0.70 |
| price to book ratio | 4.39 |
| price to sales ratio | 3.77 |
| enterprise value multiple | 33.06 |
| price fair value | 4.39 |
profitability ratios | |
|---|---|
| gross profit margin | 54.46% |
| operating profit margin | 7.34% |
| pretax profit margin | 7.78% |
| net profit margin | 5.49% |
| return on assets | 3.99% |
| return on equity | 8.75% |
| return on capital employed | 8.2% |
liquidity ratio | |
|---|---|
| current ratio | 2.34 |
| quick ratio | 1.52 |
| cash ratio | 0.77 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 318.83 |
| operating cycle | 338.72 |
| days of payables outstanding | 68.04 |
| cash conversion cycle | 270.68 |
| receivables turnover | 18.36 |
| payables turnover | 5.36 |
| inventory turnover | 1.14 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.11 |
| interest coverage | 3.69 |
| cash flow to debt ratio | 1.57 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.10 |
| cash per share | 0.47 |
| operating cash flow per share | 0.12 |
| free cash flow operating cash flow ratio | 0.85 |
| cash flow coverage ratios | 1.57 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 6.77 |
Frequently Asked Questions
When was the last time Protalix BioTherapeutics, Inc. (AMEX:PLX) reported earnings?
Protalix BioTherapeutics, Inc. (PLX) published its most recent earnings results on 14-11-2024.
What is Protalix BioTherapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Protalix BioTherapeutics, Inc. (AMEX:PLX)'s trailing twelve months ROE is 8.75%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Protalix BioTherapeutics, Inc. (PLX) currently has a ROA of 3.99%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PLX's net profit margin stand at?
PLX reported a profit margin of 5.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PLX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.34 in the most recent quarter. The quick ratio stood at 1.52, with a Debt/Eq ratio of 0.13.